tiprankstipranks
Day One Biopharmaceuticals reports Q3 EPS (53c), consensus (53c)
The Fly

Day One Biopharmaceuticals reports Q3 EPS (53c), consensus (53c)

Cash, cash equivalents and short-term investments totaled $374.3M on September 30. Based on Day One’s current operating plan, management believes it has sufficient capital resources to fund anticipated operations into 2025.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on DAWN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles